Examples of 'bortezomib' in a sentence
Meaning of "bortezomib"
Bortezomib is a noun that refers to a medication used to treat certain types of cancer
Show more definitions
- A proteasome inhibitor used in cancer treatment and chemotherapy.
How to use "bortezomib" in a sentence
Basic
Advanced
bortezomib
Bortezomib powder has to be dissolved before administration.
The numbers indicate the concentration of bortezomib in nM.
Bortezomib should be discontinued if serious reactions occur.
It is not known whether bortezomib is excreted in human milk.
Bortezomib is highly selective for the proteasome.
Imnovid with bortezomib and dexamethasone.
Bortezomib is used in the treatment of multiple myeloma.
Patients refractory to bortezomib were excluded from the study.
Bortezomib should not be given by other routes.
Antiviral prophylaxis is recommended in patients being treated with bortezomib.
Bortezomib combination treatment with dexamethasone.
There is no known specific antidote for bortezomib overdose.
Bortezomib is for single use only.
It contains the active substance bortezomib.
Bortezomib should not be administered intrathecally.
See also
Refer also to the bortezomib SmPC.
Bortezomib dosage is dependent on the individual that it is being administered to.
If you are given too much bortezomib.
This suggests bortezomib distributes widely to peripheral tissues.
The proteasome inhibitor may be bortezomib.
Bortezomib is metabolised by liver enzymes.
The additional therapeutic agent is bortezomib.
Limited information on bortezomib retreatment in relapsed multiple myeloma is available.
Examples of the proteasome inhibitor may include bortezomib.
The teratogenic potential of bortezomib has not been fully investigated.
The cancer treatment may comprise administration of bortezomib.
Caelyx is used in combination with bortezomib another anticancer medicine.
In specific embodiments the additional therapeutic agent is bortezomib.
Bortezomib combination therapy patients.
Modification of bortezomib starting dose.
Bortezomib dose modification or interruption.
The pathways of elimination of bortezomib have not been characterized in humans.
Bortezomib therapy should be withheld.
The elimination pathways of bortezomib have not been determined in humans.
Bortezomib has the following chemical structure and name.
There have been fatal cases of inadvertent intrathecal administration of bortezomib.
Withhold bortezomib treatment until symptoms of toxicity have resolved.
The active substance is bortezomib.
Bortezomib intravenous arm.
One of these previous therapies must have included bortezomib.
Bortezomib is a proteasome inhibitor.
Proteasome inhibitors such as bortezomib.
Bortezomib is a cytotoxic agent.
You go to hospital to have bortezomib.
No prior bortezomib exposure.
Bortezomib is one example.
Process for making bortezomib and intermediates for the process.
Bortezomib used to treat.
Velcade is a cancer medicine that contains the active substance bortezomib.
The bortezomib regimen.
